Severe COVID-19 is often associated with detrimental elevations in blood glucose, but the mechanisms are poorly understood. In this issue of , Wan et al. identify GP73 as a SARS-CoV-2-induced secreted factor that enhances hepatic glucose production and is necessary for SARS-CoV-2-associated glucose abnormalities.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9879606 | PMC |
http://dx.doi.org/10.1038/s42255-021-00511-7 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!